New diabetes drug doesn't increase weight

Key points
- Insulin, Glucotrol, and drugs like Avandia and Actos are all effective treatments for diabetes, but they can produce weight gain.
- Arne Astrup, from The Royal Veterinary and Agricultural University in Frederiksberg, and colleagues studied the effects of liraglutide in 33 patients with type 2 diabetes.
- Compared with placebo, liraglutide improved blood sugar control without inducing weight gain.
- This suggests to the team that, at higher doses and for longer periods of time, "liraglutide actually may have the potential to induce weight loss.
Insulin, Glucotrol, and drugs like Avandia and Actos are all effective treatments for diabetes, but they can produce weight gain. In contrast, an experimental drug called liraglutide seems to control sugar levels without this frustrating side effect, Dutch researchers report.
As reported in the journal Diabetes Care, Dr. Arne Astrup, from The Royal Veterinary and Agricultural University in Frederiksberg, and colleagues studied the effects of liraglutide in 33 patients with type 2 diabetes. The patients were randomly assigned to receive a daily infection of liraglutide or inactive "placebo" for 8 weeks.
Compared with placebo, liraglutide improved blood sugar control without inducing weight gain. In fact, patients treated with the drug were slightly more likely to experience a drop in total body fat.
This suggests to the team that, at higher doses and for longer periods of time, "liraglutide actually may have the potential to induce weight loss." A significant drop in body weight was observed in a liraglutide trial reported in June.
Liraglutide had no effect on appetite or food intake. Adverse effects were "mainly mild and related to the gastrointestinal system," the team also reports, and there were no episodes of abnormally low sugar levels during the trial.
Astrup and colleagues call for further studies to better understand "the weight profile of liraglutide."
SOURCE: Diabetes Care, August 2004.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsDiabetes increases the risk of developing and dying from breast and colon cancer
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased…
28 September 2013
NewsDoctors get good and bad safety news on diabetes drugs
Diabetes pills known as DPP-4 therapies got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure, where the heart fails to pump blood…
3 September 2013
NewsType 1 diabetes drug strikingly effective in clinical trial
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.…






